Patents by Inventor Qingyang Xu

Qingyang Xu has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11866737
    Abstract: The invention relates to a 2-isopropyl malate synthase, a genetically engineered bacterium for producing L-leucine and application thereof and belongs to the field of metabolic engineering. The genetically engineered bacterium is obtained by overexpressing an isopropyl malate synthase coding gene leuAM for relieving feedback inhibition by L-leucine, an acetohydroxy acid synthase coding gene ilvBNM for relieving feedback inhibition by L-isoleucine, a 3-isopropyl malate dehydrogenase coding gene leuB and a 3-isopropyl malate dehydratase coding gene leuCD in host cells. The genetically engineered bacterium for producing the L-leucine is free from nutritional deficiency, rapid in growth, short in fermentation period, high in yield and high in conversion rate.
    Type: Grant
    Filed: December 29, 2020
    Date of Patent: January 9, 2024
    Assignee: Tianjin University of Science and Technology
    Inventors: Chenglin Zhang, Qingyang Xu, Yanjun Li, Yu Zhang, Yingzi Li, Fuzhou Zhu, Nan Lu, Shibao Han, Xierong Dong, Zishen Wang, Hao Xu, Ziyi Li
  • Publication number: 20230109256
    Abstract: The present invention belongs to the bioengineering field, and relates to a method for fermentation production of L-theanine by using an Escherichia coli genetically engineered bacterium. The engineered bacterium is obtained by serving a strain as an original strain, wherein the strain is obtained after performing a single copy of T7RNAP, a dual copy of gmas, xylR knockout, and sucCD knockout on an Escherichia coli W3110 genome, and by integrating genes xfp, pta, acs, gltA, and ppc, and knocking out ackA on the genome. The present invention has a high yield, and stable production performance; after 20-25 h, L-theanine has a titer of 75-80 g/L, and the yield is up to 52-55%. The fermentation broth is purified by membrane separation in combination with a cation-anion resin series technique. Moreover, the one-step crystallization yield is 72.3% and the L-theanine final product has a purity of 99%.
    Type: Application
    Filed: August 17, 2022
    Publication date: April 6, 2023
    Inventors: Xiaoguang Fan, Xiaodong Liu, Jing Li, Ning Chen, Bochao Liu, Shuai Liu, Chaochao Sun, Yongchao Liu, Jiajia Teng, Mengtao Zhang, Yuanqing Ji, Yuhang Zhou, Qingyang Xu
  • Patent number: 11479795
    Abstract: The disclosure discloses a genetically engineered strain for sarcosine production as well as a construction method and application. The genetically engineered strain is obtained by using Escherichia coli as a host and by integrating a single copy of imine reductase gene dpkA on its genome; singly copying citrate synthase gene gltA; knocking out glyoxylate cycle inhibitor gene iclR; knocking out malate synthase gene aceB; integrating a single copy of isocitrate lyase gene aceA; integrating a single copy of membrane-bound transhydrogenase gene pntAB; knocking out 2-ketate reductase gene ycdW; integrating a single copy of phosphoenolpyruvate carboxylase gene ppc; and knocking out pyruvate kinase gene pykF. After system metabolism transformation, the engineered strain can synthesize sarcosine with glucose and methylamine as main raw materials. The sarcosine titer can reach 10 g/L after fermentation for 30 h in a 5 L fermenter.
    Type: Grant
    Filed: January 12, 2022
    Date of Patent: October 25, 2022
    Inventors: Xiaoguang Fan, Yuhang Zhou, Huajie Cao, Pei Xie, Jun Yang, Junyu Tian, Ning Chen, Qingyang Xu
  • Patent number: 11453898
    Abstract: The present invention belongs to the bioengineering field, and relates to a method for fermentation production of L-theanine by using an Escherichia coli genetically engineered bacterium. The engineered bacterium is obtained by serving a strain as an original strain, wherein the strain is obtained after performing a single copy of T7RNAP, a dual copy of gmas, xylR knockout, and sucCD knockout on an Escherichia coli W3110 genome, and by integrating genes xfp, pta, acs, gltA, and ppc, and knocking out ackA on the genome. The present invention has a high yield, and stable production performance; after 20-25 h, L-theanine has a titer of 75-80 g/L, and the yield is up to 52-55%. The fermentation broth is purified by membrane separation in combination with a cation-anion resin series technique. Moreover, the one-step crystallization yield is 72.3% and the L-theanine final product has a purity of 99%.
    Type: Grant
    Filed: December 31, 2021
    Date of Patent: September 27, 2022
    Assignees: Henan Julong Biological Engineering Co., Ltd, Tianjin University of Science and Technology
    Inventors: Xiaoguang Fan, Xiaodong Liu, Jing Li, Ning Chen, Bochao Liu, Shuai Liu, Chaochao Sun, Yongchao Liu, Jiajia Teng, Mengtao Zhang, Yuanqing Ji, Yuhang Zhou, Qingyang Xu
  • Publication number: 20220259625
    Abstract: The disclosure discloses a genetically engineered strain for sarcosine production as well as a construction method and application. The genetically engineered strain is obtained by using Escherichia coli as a host and by integrating a single copy of imine reductase gene dpkA on its genome; singly copying citrate synthase gene gltA; knocking out glyoxylate cycle inhibitor gene iclR; knocking out malate synthase gene aceB; integrating a single copy of isocitrate lyase gene aceA; integrating a single copy of membrane-bound transhydrogenase gene pntAB; knocking out 2-ketate reductase gene ycdW; integrating a single copy of phosphoenolpyruvate carboxylase gene ppc; and knocking out pyruvate kinase gene pykF. After system metabolism transformation, the engineered strain can synthesize sarcosine with glucose and methylamine as main raw materials. The sarcosine titer can reach 10 g/L after fermentation for 30 h in a 5 L fermenter.
    Type: Application
    Filed: January 12, 2022
    Publication date: August 18, 2022
    Inventors: Xiaoguang FAN, Yuhang ZHOU, Huajie CAO, Pei XIE, Jun YANG, Junyu TIAN, Ning CHEN, Qingyang XU
  • Patent number: 11124780
    Abstract: The present disclosure relates to a genetically engineered strain with high production of uridine and its construction method and application. The strain was constructed as follows: heterologously expressing pyrimidine nucleoside operon sequence pyrBCAKDFE (SEQ ID NO:1) on the genome of E coli prompted by strong promoter Ptrc to reconstruct the pathway of uridine synthesis; overexpressing the autologous prsA gene coding PRPP synthase by integration of another copy of prsA gene promoted by strong promoter Ptrc on the genome; deficiency of uridine kinase, uridine phosphorylase, ribonucleoside hydrolase, homoserine dehydrogenase I and ornithine carbamoyltransferase. When the bacteria was used for producing uridine, 40-67 g/L uridine could be obtained in a 5 L fermentor after fermentation for 40-70 h using the technical scheme provided by the disclosure with the maximum productivity of 0.15-0.25 g uridine/g glucose and 1.
    Type: Grant
    Filed: May 12, 2019
    Date of Patent: September 21, 2021
    Assignee: Tianjin University of Science and Technology
    Inventors: Xixian Xie, Ning Chen, Heyun Wu, Guoliang Li, Qiang Li, Xiaoguang Fan, Qingyang Xu, Chenglin Zhang, Yanjun Li, Qian Ma
  • Publication number: 20210189354
    Abstract: The invention relates to a 2-isopropyl malate synthase, a genetically engineered bacterium for producing L-leucine and application thereof and belongs to the field of metabolic engineering. The genetically engineered bacterium is obtained by overexpressing an isopropyl malate synthase coding gene leuAM for relieving feedback inhibition by L-leucine, an acetohydroxy acid synthase coding gene ilvBNM for relieving feedback inhibition by L-isoleucine, a 3-isopropyl malate dehydrogenase coding gene leuB and a 3-isopropyl malate dehydratase coding gene leuCD in host cells. The genetically engineered bacterium for producing the L-leucine is free from nutritional deficiency, rapid in growth, short in fermentation period, high in yield and high in conversion rate.
    Type: Application
    Filed: December 29, 2020
    Publication date: June 24, 2021
    Inventors: Chenglin Zhang, Qingyang Xu, Yanjun Li, Yu Zhang, Yingzi Li, Fuzhou Zhu, Nan Lu, Shibao Han, Xierong Dong, Zishen Wang, Hao Xu, Ziyi Li
  • Publication number: 20210162554
    Abstract: A stage for cutting process and cutting method thereof, processing apparatus are disclosed. The stage includes a support substrate and a driving unit disposed on the support substrate. The driving unit is configured to drive the support substrate to rotate around a first direction in a board surface of the support substrate so as to remove foreign matters on the support substrate. The driving unit disposed in the stage can drive the rotation of the stage to allow foreign matters on the stage to automatically slide down.
    Type: Application
    Filed: October 17, 2017
    Publication date: June 3, 2021
    Applicants: BOE Technology Group Co., Ltd., Hefei Xinsheng Optoelectronics Technology Co., Ltd.
    Inventors: Sheng Tao, Wenlong Zhu, Qingyang Xu, Yunze Li, Zuliang Wang
  • Patent number: 10632595
    Abstract: A bearing flatform, a bearing device and a laser cutting apparatus. The bearing flatform comprises a bearing plate and a porous film arranged on a hearing surface of the bearing plate. A plurality of first through holes penetrating through the bearing plate are formed in the bearing plate and configured to be connected with a pumping hole of an air pump.
    Type: Grant
    Filed: May 19, 2016
    Date of Patent: April 28, 2020
    Assignees: BOE TECHNOLOGY GROUP CO., LTD., HEFEI XINSHENG OPTOELECTRONICS TECHNOLOGY CO., LTD.
    Inventors: Qingyang Xu, Sheng Tao
  • Publication number: 20190264185
    Abstract: The present disclosure relates to a genetically engineered strain with high production of uridine and its construction method and application. The strain was constructed as follows: heterologously expressing pyrimidine nucleoside operon sequence pyrBCAKDFE (SEQ ID NO:1) on the genome of E coli prompted by strong promoter Ptrc to reconstruct the pathway of uridine synthesis; overexpressing the autologous prsA gene coding PRPP synthase by integration of another copy of prsA gene promoted by strong promoter Ptrc on the genome; deficiency of uridine kinase, uridine phosphorylase, ribonucleoside hydrolase, homoserine dehydrogenase I and ornithine carbamoyltransferase. When the bacteria was used for producing uridine, 40-67 g/L uridine could be obtained in a 5 L fermentator after fermentation for 40-70 h using the technical scheme provided by the discloure with the maximum productivity of 0.15-0.25 g uridine/g glucose and 1.
    Type: Application
    Filed: May 12, 2019
    Publication date: August 29, 2019
    Inventors: Xixian Xie, Ning Chen, Heyun Wu, Guoliang Li, Qiang Li, Xiaoguang Fan, Qingyang Xu, Chenglin Zhang, Yanjun Li, Qian Ma
  • Publication number: 20190009361
    Abstract: A laser processing device and a laser processing method. The laser processing device includes a cutting table, configured to load a workpiece to be processed; a distance-measuring unit, configured to perform distance measurement on the workpiece along a predetermined processing path to obtain three-dimensional processing data of the workpiece; and a laser processing unit, configured to process the workpiece by using laser light according to the three-dimensional processing data.
    Type: Application
    Filed: August 2, 2017
    Publication date: January 10, 2019
    Inventors: Lulu XU, Wenlong ZHU, Qingyang XU
  • Publication number: 20170080548
    Abstract: A bearing flatform, a bearing device and a laser cutting apparatus. The bearing flatform comprises a bearing plate and a porous film arranged on a hearing surface of the bearing plate. A plurality of first through holes penetrating through the bearing plate are formed in the bearing plate and configured to be connected with a pumping hole of an air pump.
    Type: Application
    Filed: May 19, 2016
    Publication date: March 23, 2017
    Inventors: Qingyang XU, Sheng TAO
  • Patent number: 9197027
    Abstract: The invention provides a method for making a laser module, comprising: Step 1: fixing a laser crystal and a nonlinear crystal through at least one spacing element to form a first structure; Step 2: assembling the first structure on a substrate; Step 3: removing the spacing element to form a first laser module. According to the invention, the laser crystal and the nonlinear crystal are separately fixed on a heat conductive substrate to form the laser module, thereby the size of the laser module is reduced.
    Type: Grant
    Filed: July 5, 2012
    Date of Patent: November 24, 2015
    Assignees: C2C Link Corporation, Nanjing CQ Laser Technologies, Co. Ltd.
    Inventors: Qingyang Xu, Yang Lu, Hongping Su, Xiangyang Li
  • Publication number: 20140011308
    Abstract: The invention provides a method for making a laser module, comprising: Step 1: fixing a laser crystal and a nonlinear crystal through at least one spacing element to form a first structure; Step 2: assembling the first structure on a substrate; Step 3: removing the spacing element to form a first laser module. According to the invention, the laser crystal and the nonlinear crystal are separately fixed on a heat conductive substrate to form the laser module, thereby the size of the laser module is reduced.
    Type: Application
    Filed: July 5, 2012
    Publication date: January 9, 2014
    Applicants: NANJING CQ LASER TECHNOLOGIES CO., LTD., C2C LINK CORPORATION
    Inventors: Qingyang Xu, Yang Lu, Hongping Su, Xiangyang Li